RXRX
Recursion Pharmaceuticals Inc
Price:  
7.46 
USD
Volume:  
15,840,900.00
United States | Biotechnology
Valuation
Overview
Financials
Forecast
Compare
Historical Price
SolvencyDividends
Transactions
People

RXRX WACC - Weighted Average Cost of Capital

The WACC of Recursion Pharmaceuticals Inc (RXRX) is 8.1%.

The Cost of Equity of Recursion Pharmaceuticals Inc (RXRX) is 8.10%.
The Cost of Debt of Recursion Pharmaceuticals Inc (RXRX) is 8.25%.

Range Selected
Cost of equity 6.90% - 9.30% 8.10%
Tax rate 22.10% - 22.30% 22.20%
Cost of debt 7.00% - 9.50% 8.25%
WACC 6.9% - 9.3% 8.1%
WACC

RXRX WACC calculation

Category Low High
Long-term bond rate 3.9% 4.4%
Equity market risk premium 4.6% 5.6%
Adjusted beta 0.67 0.79
Additional risk adjustments 0.0% 0.5%
Cost of equity 6.90% 9.30%
Tax rate 22.10% 22.30%
Debt/Equity ratio 0 0
Cost of debt 7.00% 9.50%
After-tax WACC 6.9% 9.3%
Selected WACC 8.1%